{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:19:26Z","timestamp":1788985166500,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biomed Eng"],"DOI":"10.1038\/s41551-021-00738-5","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T12:03:14Z","timestamp":1623672194000},"page":"1389-1401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Induction of antigen-specific tolerance by nanobody\u2013antigen adducts that target class-II major histocompatibility complexes"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8124-1265","authenticated-orcid":false,"given":"Novalia","family":"Pishesha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Harmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3850-1746","authenticated-orcid":false,"given":"Liyan Y.","family":"Smeding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2916-2164","authenticated-orcid":false,"given":"Leif S.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robine","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraful","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushu J.","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7888-7815","authenticated-orcid":false,"given":"Nicholas","family":"McCaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"William","family":"Pinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harun R.","family":"Sugito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A.","family":"Rossotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gualberto","family":"Gonzalez-Sapienza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1090-6071","authenticated-orcid":false,"given":"Hidde L.","family":"Ploegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,14]]},"reference":[{"key":"738_CR1","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.autrev.2012.02.001","volume":"11","author":"SM Hayter","year":"2012","unstructured":"Hayter, S. M. & Cook, M. C. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun. Rev. 11, 754\u2013765 (2012).","journal-title":"Autoimmun. Rev."},{"key":"738_CR2","doi-asserted-by":"publisher","first-page":"E241","DOI":"10.1371\/journal.pbio.0020241","volume":"2","author":"L Morel","year":"2004","unstructured":"Morel, L. Mouse models of human autoimmune diseases: essential tools that require the proper controls. PLoS Biol. 2, E241 (2004).","journal-title":"PLoS Biol."},{"key":"738_CR3","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1084\/jem.20032220","volume":"199","author":"LC Bonifaz","year":"2004","unstructured":"Bonifaz, L. C. et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199, 815\u2013824 (2004).","journal-title":"J. Exp. Med."},{"key":"738_CR4","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1073\/pnas.1019547108","volume":"108","author":"J Idoyaga","year":"2011","unstructured":"Idoyaga, J. et al. Comparable T helper 1 (TH1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proc. Natl Acad. Sci. USA 108, 2384\u20132389 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"738_CR5","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1084\/jem.20021598","volume":"196","author":"L Bonifaz","year":"2002","unstructured":"Bonifaz, L. et al. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196, 1627\u20131638 (2002).","journal-title":"J. Exp. Med."},{"key":"738_CR6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1084\/jem.194.6.769","volume":"194","author":"D Hawiger","year":"2001","unstructured":"Hawiger, D. et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194, 769\u2013779 (2001).","journal-title":"J. Exp. Med."},{"key":"738_CR7","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.4049\/jimmunol.1600692","volume":"197","author":"JN Duarte","year":"2016","unstructured":"Duarte, J. N. et al. Generation of immunity against pathogens via single-domain antibody\u2013antigen constructs. J. Immunol. 197, 4838\u20134847 (2016).","journal-title":"J. Immunol."},{"key":"738_CR8","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.2967\/jnumed.116.186007","volume":"58","author":"C Van Elssen","year":"2017","unstructured":"Van Elssen, C. et al. Noninvasive imaging of human immune responses in a human xenograft model of graft-versus-host disease. J. Nucl. Med. 58, 1003\u20131008 (2017).","journal-title":"J. Nucl. Med."},{"key":"738_CR9","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1002\/anie.201509432","volume":"55","author":"T Fang","year":"2016","unstructured":"Fang, T. et al. Structurally defined \u03b1MHC-II nanobody\u2013drug conjugates: a therapeutic and imaging system for B-cell lymphoma. Angew. Chem. Int. Ed. Engl. 55, 2416\u20132420 (2016).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"738_CR10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1146\/annurev-immunol-042617-053327","volume":"36","author":"JR Ingram","year":"2018","unstructured":"Ingram, J. R., Schmidt, F. I. & Ploegh, H. L. Exploiting nanobodies\u2019 singular traits. Annu. Rev. Immunol. 36, 695\u2013715 (2018).","journal-title":"Annu. Rev. Immunol."},{"key":"738_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev-cellbio-100617-062527","volume":"34","author":"N Pishesha","year":"2018","unstructured":"Pishesha, N., Ingram, J. R. & Ploegh, H. L. Sortase A: a model for transpeptidation and its biological applications. Annu. Rev. Cell Dev. Biol. 34, 163\u2013188 (2018).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"738_CR12","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nri2103","volume":"7","author":"JA Villadangos","year":"2007","unstructured":"Villadangos, J. A. & Schnorrer, P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat. Rev. Immunol. 7, 543\u2013555 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"738_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-1-4939-7862-5_17","volume":"1791","author":"M Giralt","year":"2018","unstructured":"Giralt, M., Molinero, A. & Hidalgo, J. Active induction of experimental autoimmune encephalomyelitis (EAE) with MOG35-55 in the mouse. Methods Mol. Biol. 1791, 227\u2013232 (2018).","journal-title":"Methods Mol. Biol."},{"key":"738_CR14","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nature01004","volume":"418","author":"M Boes","year":"2002","unstructured":"Boes, M. et al. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature 418, 983\u2013988 (2002).","journal-title":"Nature"},{"key":"738_CR15","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/nm.4200","volume":"22","author":"KD Moynihan","year":"2016","unstructured":"Moynihan, K. D. et al. Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses. Nat. Med. 22, 1402\u20131410 (2016).","journal-title":"Nat. Med."},{"key":"738_CR16","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1002\/eji.201142239","volume":"42","author":"M Isaksson","year":"2012","unstructured":"Isaksson, M. et al. Conditional DC depletion does not affect priming of encephalitogenic TH cells in EAE. Eur. J. Immunol. 42, 2555\u20132563 (2012).","journal-title":"Eur. J. Immunol."},{"key":"738_CR17","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/eji.201040992","volume":"41","author":"S Bodhankar","year":"2011","unstructured":"Bodhankar, S. et al. Estrogen-induced protection against experimental autoimmune encephalomyelitis is abrogated in the absence of B cells. Eur. J. Immunol. 41, 1165\u20131175 (2011).","journal-title":"Eur. J. Immunol."},{"key":"738_CR18","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1126\/science.1164206","volume":"322","author":"K Hildner","year":"2008","unstructured":"Hildner, K. et al. Batf3 deficiency reveals a critical role for CD8\u03b1+ dendritic cells in cytotoxic T cell immunity. Science 322, 1097\u20131100 (2008).","journal-title":"Science"},{"key":"738_CR19","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1084\/jem.20021603","volume":"197","author":"E Bettelli","year":"2003","unstructured":"Bettelli, E. et al. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197, 1073\u20131081 (2003).","journal-title":"J. Exp. Med."},{"key":"738_CR20","doi-asserted-by":"publisher","first-page":"101305","DOI":"10.1016\/j.smim.2019.101305","volume":"42","author":"E Ruffo","year":"2019","unstructured":"Ruffo, E. et al. Lymphocyte-activation gene 3 (LAG3): the next immune checkpoint receptor. Semin. Immunol. 42, 101305 (2019).","journal-title":"Semin. Immunol."},{"key":"738_CR21","doi-asserted-by":"publisher","first-page":"101.7","DOI":"10.4049\/jimmunol.200.Supp.101.7","volume":"200","author":"YR Thaker","year":"2018","unstructured":"Thaker, Y. R. et al. Treg-specific LAG3 deletion reveals a key role for LAG3 in regulatory T cells to inhibit CNS autoimmunity. J. Immunol. 200, 101.7 (2018).","journal-title":"J. Immunol."},{"key":"738_CR22","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1084\/jem.20141030","volume":"212","author":"AM Paterson","year":"2015","unstructured":"Paterson, A. M. et al. Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity. J. Exp. Med. 212, 1603\u20131621 (2015).","journal-title":"J. Exp. Med."},{"key":"738_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/ni1428","volume":"8","author":"JM Kim","year":"2007","unstructured":"Kim, J. M., Rasmussen, J. P. & Rudensky, A. Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8, 191\u2013197 (2007).","journal-title":"Nat. Immunol."},{"key":"738_CR24","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/0092-8674(93)90730-E","volume":"74","author":"JD Katz","year":"1993","unstructured":"Katz, J. D. et al. Following a diabetogenic T cell from genesis through pathogenesis. Cell 74, 1089\u20131100 (1993).","journal-title":"Cell"},{"key":"738_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4049\/jimmunol.173.1.151","volume":"173","author":"P Maffia","year":"2004","unstructured":"Maffia, P. et al. Inducing experimental arthritis and breaking self-tolerance to joint-specific antigens with trackable, ovalbumin-specific T cells. J. Immunol. 173, 151\u2013156 (2004).","journal-title":"J. Immunol."},{"key":"738_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0092-8674(94)90169-4","volume":"76","author":"KA Hogquist","year":"1994","unstructured":"Hogquist, K. A. et al. T cell receptor antagonist peptides induce positive selection. Cell 76, 17\u201327 (1994).","journal-title":"Cell"},{"key":"738_CR27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.celrep.2012.03.009","volume":"1","author":"S Sehrawat","year":"2012","unstructured":"Sehrawat, S. et al. CD8+ T cells from mice transnuclear for a TCR that recognizes a single H-2Kb-restricted MHV68 epitope derived from gB-ORF8 help control infection. Cell Rep. 1, 461\u2013471 (2012).","journal-title":"Cell Rep."},{"key":"738_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1084\/jem.20131603","volume":"211","author":"AM Avalos","year":"2014","unstructured":"Avalos, A. M. et al. Monovalent engagement of the BCR activates ovalbumin-specific transnuclear B cells. J. Exp. Med. 211, 365\u2013379 (2014).","journal-title":"J. Exp. Med."},{"key":"738_CR29","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1039\/C8CS00676H","volume":"48","author":"JD Bargh","year":"2019","unstructured":"Bargh, J. D. et al. Cleavable linkers in antibody\u2013drug conjugates. Chem. Soc. Rev. 48, 4361\u20134374 (2019).","journal-title":"Chem. Soc. Rev."},{"key":"738_CR30","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3389\/fimmu.2018.01169","volume":"9","author":"G Florez-Grau","year":"2018","unstructured":"Florez-Grau, G. et al. Tolerogenic dendritic cells as a promising antigen-specific therapy in the treatment of multiple sclerosis and neuromyelitis optica from preclinical to clinical trials. Front Immunol. 9, 1169 (2018).","journal-title":"Front Immunol."},{"key":"738_CR31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41409-019-0684-0","volume":"55","author":"B Sharrack","year":"2020","unstructured":"Sharrack, B. et al. Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE). Bone Marrow Transpl. 55, 283\u2013306 (2020).","journal-title":"Bone Marrow Transpl."},{"key":"738_CR32","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1073\/pnas.1701746114","volume":"114","author":"N Pishesha","year":"2017","unstructured":"Pishesha, N. et al. Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease. Proc. Natl Acad. Sci. USA 114, 3157\u20133162 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"738_CR33","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41551-019-0424-1","volume":"3","author":"DS Wilson","year":"2019","unstructured":"Wilson, D. S. et al. Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes. Nat. Biomed. Eng. 3, 817\u2013829 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"738_CR34","doi-asserted-by":"publisher","first-page":"E60","DOI":"10.1073\/pnas.1216353110","volume":"110","author":"S Kontos","year":"2013","unstructured":"Kontos, S. et al. Engineering antigens for in situ erythrocyte binding induces T-cell deletion. Proc. Natl Acad. Sci. USA 110, E60\u2013E68 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"738_CR35","doi-asserted-by":"publisher","first-page":"e1500112","DOI":"10.1126\/sciadv.1500112","volume":"1","author":"KM Lorentz","year":"2015","unstructured":"Lorentz, K. M. et al. Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase. Sci. Adv. 1, e1500112 (2015).","journal-title":"Sci. Adv."},{"key":"738_CR36","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3389\/fimmu.2018.00230","volume":"9","author":"TK Kishimoto","year":"2018","unstructured":"Kishimoto, T. K. & Maldonado, R. A. Nanoparticles for the induction of antigen-specific immunological tolerance. Front. Immunol. 9, 230 (2018).","journal-title":"Front. Immunol."},{"key":"738_CR37","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.addr.2017.04.005","volume":"114","author":"RM Pearson","year":"2017","unstructured":"Pearson, R. M. et al. In vivo reprogramming of immune cells: technologies for induction of antigen-specific tolerance. Adv. Drug Deliv. Rev. 114, 240\u2013255 (2017).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"738_CR38","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.it.2017.07.007","volume":"38","author":"CA Iberg","year":"2017","unstructured":"Iberg, C. A., Jones, A. & Hawiger, D. Dendritic cells as inducers of peripheral tolerance. Trends Immunol. 38, 793\u2013804 (2017).","journal-title":"Trends Immunol."},{"key":"738_CR39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1146\/annurev.immunol.21.120601.141040","volume":"21","author":"RM Steinman","year":"2003","unstructured":"Steinman, R. M., Hawiger, D. & Nussenzweig, M. C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685\u2013711 (2003).","journal-title":"Annu. Rev. Immunol."},{"key":"738_CR40","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nature16962","volume":"530","author":"X Clemente-Casares","year":"2016","unstructured":"Clemente-Casares, X. et al. Expanding antigen-specific regulatory networks to treat autoimmunity. Nature 530, 434\u2013440 (2016).","journal-title":"Nature"},{"key":"738_CR41","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.immuni.2015.02.010","volume":"42","author":"JG Henderson","year":"2015","unstructured":"Henderson, J. G., Opejin, A., Jones, A., Gross, C. & Hawiger, D. CD5 instructs extrathymic regulatory T cell development in response to self and tolerizing antigens. Immunity 42, 471\u2013483 (2015).","journal-title":"Immunity"},{"key":"738_CR42","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S0952-7915(96)80012-4","volume":"8","author":"CJ Vanderlugt","year":"1996","unstructured":"Vanderlugt, C. J. & Miller, S. D. Epitope spreading. Curr. Opin. Immunol. 8, 831\u2013836 (1996).","journal-title":"Curr. Opin. Immunol."},{"key":"738_CR43","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1146\/annurev-immunol-032712-095941","volume":"32","author":"ER Unanue","year":"2014","unstructured":"Unanue, E. R. Antigen presentation in the autoimmune diabetes of the NOD mouse. Annu. Rev. Immunol. 32, 579\u2013608 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"738_CR44","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1208\/s12248-014-9710-8","volume":"17","author":"JR McCombs","year":"2015","unstructured":"McCombs, J. R. & Owen, S. C. Antibody drug conjugates: design and selection of linker, payload and conjugation chemistry. AAPS J. 17, 339\u2013351 (2015).","journal-title":"AAPS J."},{"key":"738_CR45","doi-asserted-by":"publisher","first-page":"11206","DOI":"10.1002\/anie.201903498","volume":"58","author":"KC Nicolaou","year":"2019","unstructured":"Nicolaou, K. C. & Rigol, S. The role of organic synthesis in the emergence and development of antibody\u2013drug conjugates as targeted cancer therapies. Angew. Chem. Int. Ed. Engl. 58, 11206\u201311241 (2019).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"738_CR46","doi-asserted-by":"publisher","first-page":"6146","DOI":"10.1073\/pnas.1502609112","volume":"112","author":"M Rashidian","year":"2015","unstructured":"Rashidian, M. et al. Noninvasive imaging of immune responses. Proc. Natl Acad. Sci. USA 112, 6146\u20136151 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-021-00738-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-021-00738-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-021-00738-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T10:13:09Z","timestamp":1675419189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-021-00738-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,14]]},"references-count":46,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["738"],"URL":"https:\/\/doi.org\/10.1038\/s41551-021-00738-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-192181\/v1","asserted-by":"object"}]},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,14]]},"assertion":[{"value":"5 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Boston Children\u2019s Hospital has filed for patent protection (US Provisional Application Serial No. 63\/154,455) on the technology described here, and N.P., T.H. and H.L.P. are named as inventors on those patents. The rest of the authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}